Dr Reddy’s Labs net profit doubles in Q1: What should investors do? - Economic Times

Share of the pharma major fell about 4 per cent in the first one hour of the trade on Friday. Experts see concerns over the US business, as well as, pressure on operating performance as key drags. Despite near-term headwinds, most brokerage firms maintained t…

Dr Reddys Laboratories failed to cheer Dalal Street despite reporting over a 100 per cent rise in the net profit for the quarter ended June 2022. Share of the pharma major fell about 4 per cent in t… [+3137 chars]

full article...